How does increasing acetaminophen doses affect NAPQI and hepatic injury?

How does increasing acetaminophen doses affect NAPQI and hepatic injury?

• A. No effect
• B. Increased NAPQI leading to hepatic injury
• C. Decreased NAPQI
• D. NAPQI only at chronic use

Answer: (B)

Increasing acetaminophen doses pushes more drug through the cytochrome P450 pathway to form NAPQI, a highly reactive metabolite. At therapeutic doses, acetaminophen is mainly detoxified by conjugation to sulfate and glucuronide, with only a small amount becoming NAPQI, and that NAPQI is rapidly neutralized by glutathione. When the dose is higher, more acetaminophen is converted to NAPQI than glutathione can neutralize, leading to glutathione depletion. With insufficient detoxification, NAPQI accumulates and binds to hepatic cellular proteins, causing oxidative stress, mitochondrial dysfunction, and hepatocellular injury. Clinically, this is why toxicity is dose-dependent and why N-acetylcysteine is used to replenish glutathione and restore detoxification capacity.

Increasing acetaminophen doses pushes more drug through the cytochrome P450 pathway to form NAPQI, a highly reactive metabolite. At therapeutic doses, acetaminophen is mainly detoxified by conjugation to sulfate and glucuronide, with only a small amount becoming NAPQI, and that NAPQI is rapidly neutralized by glutathione. When the dose is higher, more acetaminophen is converted to NAPQI than glutathione can neutralize, leading to glutathione depletion. With insufficient detoxification, NAPQI accumulates and binds to hepatic cellular proteins, causing oxidative stress, mitochondrial dysfunction, and hepatocellular injury. Clinically, this is why toxicity is dose-dependent and why N-acetylcysteine is used to replenish glutathione and restore detoxification capacity.